About Hôpital Porte Madeleine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Association de Recherche Clinique en Rhumatologie
1
Genzyme, a Sanofi Company
1
Clinical Trials at Hôpital Porte Madeleine
During the past decade, Hôpital Porte Madeleine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
2003-04-01
2004-12-01
Completed
240
Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies
2003-04-01
2006-07-01
Completed
7
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Porte Madeleine"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hôpital Porte Madeleine
According to Clinical.Site data, the most researched conditions in "Hôpital Porte Madeleine" are
"Ankylosing Spondylitis" (1 trials), "Glycogen Storage Disease Type II" (1 trials), "Pompe Disease Infantile-Onset" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hôpital Porte Madeleine" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Porte Madeleine
Most popular intervention types in "Hôpital Porte Madeleine" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials), "Etanercept" (1 trials) and "Myozyme" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Porte Madeleine
The vast majority of trials in "Hôpital Porte Madeleine" are
4 trials for "All" genders.
Clinical Trials Status at Hôpital Porte Madeleine
Currently, there are NaN active trials in "Hôpital Porte Madeleine".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hôpital Porte Madeleine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Porte Madeleine, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".